Genetic modification of primate hemopoietic repopulating stem cells
EP1195440A1
Gene delivery vectors for stem cells
EP1191104A1
Gene delivery vehicles and use thereof in the preparation of a medicament and/or vaccine
EP1083228A1
Modified adenoviral vectors for use in gene therapy
AU6600400A
Methods and means for inhibiting angiogenesis
EP1157999A1
Methods and means for enhancing skin transplantation using gene delivery vehicles having tropism for primary fibroblasts, as well as other uses thereof
EP1016727A1
Gene therapy to promote angiogenesis.
EP1106185A1
Method of administering adenovirus
EP1103610A1
Production of vaccines from immortalised mammalian cell lines
IL133032D0
Adenoviral gene delivery vectors provided with a tissue tropism for smooth muscle cells and /or endothelial cells
EP1121429A2
Gene therapy of alzheimer's disease by delivery of an encoded apolipoprotein e
EP1083229A1
Modified adenoviral vectors for use in gene therapy
EP1083231A1
Smooth muscle cell promoter and uses thereof
US6265212B1
Packaging systems for human recombinant adenovirus to be used in gene therapy
EP1067190A1
Gene therapy for enhancing and/or inducing angiogenesis
EP1067188A1
Infection with chimaeric adenoviruses of cells negative for the adenovirus serotype 5 Coxsacki adenovirus receptor (CAR)
CA2303477A1
Chimaeric adenoviruses
WO9964582A2
High-throughput screening of gene function using libraries for functional genomics applications
EP0960942A2
Targeted delivery through a cationic amino acid transporter
EP0972841A1
Display of viral proteins as ligands for cell-surface receptor
